Abstract
The successful transfer of clinical practice guidelines (CPGs) into patient care depends on the appropriateness of the implementation method. This study strived for a better understanding of which intervention strategy is effective in implementing the CPG on Parkinson’s disease (CPG-PD). In a cluster randomized controlled trial, we compared the impact of two different implementation strategies of the CPG-PD on health outcomes of PD patients. The primary outcome of health-related quality of life was measured by PDQ-39. The neurologists of the intervention group (IG) versus a control group (CG) received the CPG-PD with special instructions, a 4-h training and were offered personal feedback. Patients were followed over three assessment times: baseline, post-test (6 months) and follow-up (9 months). Lack of time and remuneration resulted in low study participation (32 out of 619 contacted neurologists). Multilevel modelling revealed that primary (PDQ-39) and secondary efficacy variables (EQ-5D, CGI, HADS-D, ZUF-8) of 386 patients were not affected significantly by the intervention and failed to show any significant difference between the two groups. The EQ-5D VAS scale (p = 0.0288) and the CGI-P severity scale (p = 0.0072) showed a significant worsening over time. A significant decrease of hours of dyskinesias in the IG (p = 0.007) was observed, whereas Parkinson symptoms did not change significantly between the groups. Lacking awareness of the CPG-PD seems to be no longer a barrier for its use, but it is still a major challenge to find effective implementation methods to optimise clinical outcome. Further studies are needed for a more comprehensive understanding of successful implementation strategies.
Similar content being viewed by others
References
Grol R, Grimshaw J (2003) From best evidence to best practice: effective implementation of change in patients’ care. Lancet 362:1225–1230
Grimshaw JM, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317–1322
Davis DA, Taylor-Vaisey A (1997) Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 157:408–416
Gross PA, Pujat D (2001) Implementing practice guidelines for appropriate antimicrobial usage: a systematic review. Med Care 39:1155–1169
Heinemann AW, Elliot JR, Rychlik K, Klaren P, King C, Clumpner J (2003) The impact of stroke practice guidelines on knowledge and practice patterns of acute care health professionals. J Eval Clin Pract 9:203–212
Simpson SH, Marrie TJ, Majumdar SR (2005) Do guidelines guide pneumonia practice? A systematic review of interventions and barriers to best practice in the management of community-acquired pneumonia. Respir Care Clin N Am 11:1–13
Mulder SA, Ouwendijk R, van Leerdam M, Nagengast F, Kuipers E (2008) A nationwide survey evaluating adherence to guidelines for follow-up after polypectomy or treatment for colorectal cancer. J Clin Gastroenterol 42:487–492
Francke AL, Smit MC, de Veer AJ, Mistiaen P (2008) Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 8:38
Arroll B (2003) Why are guidelines not used and what can be done to change that? nzfp 30:324–326
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA et al (1999) Why don’t physicians follow clinical practice guidelines? JAMA 282:1458–1465
Brouwers MC, Graham ID, Hanna SE, Cameron DA, Browman GP (2004) Clinicians’ assessments of practice guidelines in oncology: the CAPGO survey. Int J Technol Assess Health Care 20:421–426
Van der Weijden T, Hooi J, Grol R, Martien X (2004) A multidisciplinary guideline for the acute phase of stroke: barriers perceived by Dutch neurologists. J Eval Clin Pract 10:241–246
Larisch A, Oertel WH, Eggert K (2009) Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson’s disease. A national survey of German neurologists in private practice. J Neurol 256:1681–1688
Russell IT, Grimshaw JM (1992) The effectiveness of referral guidelines: a review of the methods and findings of published evaluations. In: Roland M, Coulter A (eds) Hospital referrals. Oxford University Press, Oxford, pp 179–211
Freemantle N (2000) Implementation strategies. Fam Pract 17:7–11
Devinsky O (1995) Outcome research in neurology: incorporating health-related quality of life. Ann Neurol 37:141–142
Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69:308–312
The Global Parkinson’s Disease Survey Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17:60–67
Schrag A (2006) Quality of life and depression in Parkinson’s disease. J Neurol Science 248:151–157
Eggert K, Oertel WH, Reichmann H, Arnold G, Baas H, Berg D et al (2008) Clinical practice guideline on Parkinsonian syndrome: diagnostics and therapy, 4th edn. Thieme Verlag, Stuttgart
Eggert K, Larisch A, Dodel R, Bormann C, Oertel WH (2009) Awareness and knowledge of the clinical practice guideline on Parkinson’s disease among Neurologists in Germany. Eur Neurol 61:216–222
Altman DG, Bland JM (1997) Statistics notes: units of analysis. BMJ 314:1874
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hymann N (1979) The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357
EuroQol Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16:199–208
Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. U.S. Department of Health, Education, and Welfare, Rockville, MD
Herrmann C, Buss U, Snaith RP (1995) Hospital anxiety and depression scale––Deutsche Version (HADS-D). Manual. Hans Huber, Bern
Schmidt J, Lamprecht F, Wittmann WW (1989) Satisfaction with inpatient management. Development of a questionnaire and initial validity studies. Psychother Psychosom Med Psychol 39:248–255
Fahn S, Elton RL, UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan, Florham Park, pp 153–163
Singer JD (1998) Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J Educ Behav Stat 23:323–355
Verbeke G, Molenberghs G (2000) Linear mixed models for longitudinal data. Springer, New York
Liang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrica 73:13–22
Tunis SR, Hayward RS, Wilson MC, Rubin HR, Bass EB, Johnston M et al (1994) Internists’ attitudes about clinical practice guidelines. Ann Intern Med 120:956–963
Bauer MS (2002) A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv Rev Psychiatry 10:138–153
Tooher R, Middleton P, Babidge W (2003) Implementation of pressure ulcer guidelines: what constitutes a successful strategy? J Wound Care 12:373–382
Effective Health Care (1994) Implementing clinical practice guidelines: can guidelines be used to improve clinical practice? Bulletin No. 8. University of Leeds, Leeds
Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L et al (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8:1–72
Grimshaw J, Eccles M, Thomas R et al (2006) Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966–1998. J Gen Intern Med 21:4–20
Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K et al (2007) Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat Disord 13:108–114
Behari M, Srivastava A, Pandey R (2005) Quality of life in patients with Parkinson’s disease. Parkinsonism Relat Disord 11:221–226
Godau J, Spinnler N, Wevers AK, Trenkwalder C, Berg D (2010) Poor effect of guideline based treatment of restless legs syndrome in clinical practice. J Neurol Neurosurg Psychiatry 30 (Epub ahead of print)
Acknowledgments
The authors thank all those neurologists and their patients who participated in the study. We are indebted to research assistant Heiko Löwer, statistical advisor Nicole Burchardi, secu trial operator Gisela Anthony and the Hessian State Board of Physicians (Landesärztekammer Hessen). The study was supported by the Willy Robert Pitzer Foundation Grant No. 35/06 and the BMBF (CNP Grant No. 01 GI 0401).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Larisch, A., Reuss, A., Oertel, W.H. et al. Does the clinical practice guideline on Parkinson’s disease change health outcomes? A cluster randomized controlled trial. J Neurol 258, 826–834 (2011). https://doi.org/10.1007/s00415-010-5848-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-010-5848-1